Evaluation of a Novel Method for Increasing Intraocular Pressure in Healthy Subjects

Sponsor
Medical University of Vienna (Other)
Overall Status
Completed
CT.gov ID
NCT04044274
Collaborator
(none)
13
1
1
18.4
0.7

Study Details

Study Description

Brief Summary

Adequate perfusion is necessary for maintaining tissue function. This applies also for the eye, in which ocular perfusion pressure (OPP) is generally estimated as the difference between mean arterial pressure (MAP) and intraocular pressure (IOP). In the latter formula, IOP substitutes for central retinal venous pressure (CRVP), which is assumed to be slightly higher than IOP to allow blood flow to exit the eye. It has, however, been found that in some patients CRVP is elevated and significantly higher than IOP, which would lead to a decrease in OPP which is not taken in account with the proposed formula. Therefore, techniques for measurement of CRVP are warranted. Recently, a new, method for measurement of this parameter without corneal contact has been introduced. Briefly, with this method, IOP is elevated until the vein collapses, which then equals CRVP. In the present study this technique will be applied in 12 healthy subjects to validate whether the values that are preset by the device correlate to measurements obtained with standard Goldmann applanation tonometry. For this purpose, IOP will be experimentally increased in steps of approximately 5mmHg until it reaches 40mmHg as measured by applanation tonometry. After a resting period of 30 minutes, IOP will be again increased stepwise to 40 mmHg while retinal vessel diameters will be monitored using dynamic vessel analyzer. During this session CRVP will be measured. After another resting period of 30 minutes IOP will be stepwise increased a third time and after each step OCT, OCT-A and OCT EDI will be performed.

Condition or Disease Intervention/Treatment Phase
  • Device: IOPstim
  • Device: Suction Cup
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
13 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Evaluation of a Novel Method for Increasing Intraocular Pressure in Healthy Subjects
Actual Study Start Date :
Jul 24, 2019
Actual Primary Completion Date :
Feb 2, 2021
Actual Study Completion Date :
Feb 2, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: IOPstim

Device: IOPstim
IOPstim (IMEDOS, Jena, Germany) is a device exerting defined pressure to the sclera and hence increasing IOP.

Device: Suction Cup
Suction Cup is a device exerting defined suction to the clear and hence increasing IOP

Outcome Measures

Primary Outcome Measures

  1. Intraocular pressure (IOP) [15 Minutes]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Men and women aged between 18 and 35 years

  • Non-smokers

  • Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant

  • Normal ophthalmic findings, ametropia < 1 Dpt.

Exclusion Criteria:
  • Regular use of medication, abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study

  • Treatment in the previous 3 weeks with any drug (except contraceptives)

  • Symptoms of a clinically relevant illness in the 3 weeks before the first study day

  • Blood donation during the previous 3 weeks

  • Pregnancy, planned pregnancy or lactating

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Clinical Pharmacology, Medical University of Vienna Vienna Austria

Sponsors and Collaborators

  • Medical University of Vienna

Investigators

  • Principal Investigator: Gerhard Garhöfer, MD, Department of Clinical Pharmacology, Medical University of Vienna

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gerhard Garhofer, Assoc. Prof. Priv.-Doz. Dr., Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT04044274
Other Study ID Numbers:
  • OPHT-120219
First Posted:
Aug 5, 2019
Last Update Posted:
Apr 7, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 7, 2022